| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers K > Headlines for K-V Pharmaceutical Co. > News item |
K-V Pharmaceutical records $4.09 million operating loss for August
By Caroline Salls
Pittsburgh, Sept. 26 - K-V Pharmaceutical Co. reported a $4.09 million operating loss for the month ended Aug. 31 on $4.19 million in net revenues, according to its monthly operating report filed Wednesday with the Securities and Exchange Commission.
The net loss from continuing operations for the month was $7.51 million,
In addition, K-V had $29.08 million in cash and cash equivalents as of Aug. 31.
K-V Pharmaceutical, a St. Louis specialty pharmaceutical company, filed for bankruptcy on Aug. 4 in the U.S. Bankruptcy Court for the Southern District of New York. The Chapter 11 case number is 12-13346.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.